In healthy volunteers, taking flucloxacillin with food does not compromise effective plasma concentrations in most circumstances
Open Access
- 12 July 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 13 (7) , e0199370
Abstract
It is usually recommended that flucloxacillin is given on an empty stomach. The aim of this study was to compare total and free flucloxacillin concentrations after oral flucloxacillin, given with and without food, based on contemporary pharmacokinetic and pharmacodynamic targets. Flucloxacillin 1000 mg orally was given to 12 volunteers, after a standardised breakfast and while fasting, on two separate occasions. Flucloxacillin concentrations over 12 hours were measured by liquid chromatography-tandem mass spectrometry. Pharmacokinetic parameters, and pharmacodynamic endpoints related to target concentration achievement, were compared in the fed and fasting states. For free flucloxacillin, the fed/fasting area under the concentration-time curve from zero to infinity (AUC0-∞) ratio was 0.80 (pCmax) ratio 0.51 (pTmax) ratio 2.2 (p0-∞ and Cmax, and prolonged the Tmax of both free and total flucloxacillin concentrations compared with the fasting state, but achievement of free concentration targets associated with efficacy was in most circumstances equivalent. These results suggest that taking flucloxacillin with food is unlikely to compromise efficacy in most circumstances.Keywords
Funding Information
- New Zealand Pharmacy Education and Research Foundation (Wellington) (260)
- Jim and Mary Carney Charitable Trust
This publication has 20 references indexed in Scilit:
- Staphylococcus aureusis the most common identified cause of cellulitis: a systematic reviewEpidemiology and Infection, 2009
- Population Pharmacokinetics at Two Dose Levels and Pharmacodynamic Profiling of FlucloxacillinAntimicrobial Agents and Chemotherapy, 2007
- Activity of Nadifloxacin (OPC-7251) and Seven Other Antimicrobial Agents against Aerobic and Anaerobic Gram-Positive Bacteria Isolated from Bacterial Skin InfectionsChemotherapy, 2004
- The Pharmacodynamics of β‐LactamsClinical Infectious Diseases, 1998
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Bacteriology of Skin and Soft-Tissue Infections: Comparison of Infections in Intravenous Drug Users and Individuals with No History of Intravenous Drug UseClinical Infectious Diseases, 1995
- Dicloxacillin and flucloxacillin: Pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administrationInfection, 1995
- Pharmacokinetics and Bioavailability of Flucloxacillin in Elderly Hospitalized PatientsThe Journal of Clinical Pharmacology, 1995
- Correlation of Antimicrobial Pharmacokinetic Parameters with Therapeutic Efficacy in an Animal ModelThe Journal of Infectious Diseases, 1988
- Flucloxacillin, a New Isoxazolyl Penicillin, Compared with Oxacillin, Cloxacillin, and DicloxacillinBMJ, 1970